CHESTER, N.J., Nov. 22 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. , today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to an offering of common stock by certain stockholders of the Company.
The selling stockholders are offering 5,645,980 shares of common stock and have granted the underwriters an option to purchase up to an additional 846,873 shares to cover over-allotments, if any. The Company will not receive any proceeds from the transaction.
Merrill Lynch & Co. and Morgan Stanley & Co. Incorporated are acting as joint book-running managers for the offering. In addition, Deutsche Bank Securities and RBC Capital Markets are acting as co-managers for the offering.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
When available, copies of the preliminary prospectus relating to the offering may be obtained from: Merrill Lynch & Co., 4 World Financial Center, New York, New York 10080 (telephone: 212-449-1000) or Morgan Stanley & Co. Incorporated, Prospectus Department, 180 Varick Street, 2nd floor, New York, New York 10014 (telephone: 917-606-8474).
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.
CONTACT: Investors or Media: Janet M. Barth of Adams RespiratoryTherapeutics, Inc., +1-908-879-2428
Web site: http://www.adamsrt.com/
